{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T05:15:00Z","timestamp":1788844500946,"version":"build-2803163510"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T00:00:00Z","timestamp":1660348800000},"content-version":"am","delay-in-days":316,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.metabol.2021.154861","type":"journal-article","created":{"date-parts":[[2021,8,8]],"date-time":"2021-08-08T04:32:09Z","timestamp":1628397129000},"page":"154861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake"],"prefix":"10.1016","volume":"123","author":[{"given":"Yuyan","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sora Q.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kee-Hong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2021.154861_bb0005","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1172\/JCI108028","article-title":"Human adipocyte cholesterol. Concentration, localization, synthesis, and turnover","volume":"55","author":"Schreibman","year":"1975","journal-title":"J Clin Invest"},{"key":"10.1016\/j.metabol.2021.154861_bb0010","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0022-2275(20)37830-5","article-title":"Adipose tissue and cholesterol metabolism","volume":"25","author":"Krause","year":"1984","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0015","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-2275(20)36728-6","article-title":"Regulation of cholesterol synthesis and storage in fat cells","volume":"16","author":"Kovanen","year":"1975","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0020","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1194\/jlr.M300267-JLR200","article-title":"HDL-mediated cholesterol uptake and targeting to lipid droplets in adipocytes","volume":"44","author":"Dagher","year":"2003","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0025","doi-asserted-by":"crossref","first-page":"16904","DOI":"10.1074\/jbc.M010955200","article-title":"Cholesterol, a cell size-dependent signal that regulates glucose metabolism and gene expression in adipocytes","volume":"276","author":"Le Lay","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0030","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/ATVBAHA.117.309880","article-title":"Targeted deletion of adipocyte Abca1 (ATP-binding cassette transporter A1) impairs diet-induced obesity","volume":"38","author":"Cuffe","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.metabol.2021.154861_bb0035","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41580-019-0190-7","article-title":"Mechanisms and regulation of cholesterol homeostasis","volume":"21","author":"Luo","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.metabol.2021.154861_bb0040","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0021-9258(18)70543-7","article-title":"The esterification of cholesterol with palmitic acid by rat liver homogenates","volume":"230","author":"Mukherjee","year":"1958","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0045","doi-asserted-by":"crossref","first-page":"20747","DOI":"10.1016\/S0021-9258(19)36846-2","article-title":"Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells","volume":"268","author":"Chang","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0050","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/S0022-2275(20)37168-6","article-title":"Tissue expression studies on the mouse acyl-CoA: cholesterol acyltransferase gene (Acact): findings supporting the existence of multiple cholesterol esterification enzymes in mice","volume":"38","author":"Meiner","year":"1997","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0055","doi-asserted-by":"crossref","first-page":"26755","DOI":"10.1074\/jbc.273.41.26755","article-title":"ACAT-2, a second mammalian acyl-CoA:cholesterol acyltransferase. Its cloning, expression, and characterization","volume":"273","author":"Cases","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0060","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.90926.2008","article-title":"Acyl-coenzyme A:cholesterol acyltransferases","volume":"297","author":"Chang","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154861_bb0065","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1016\/S0022-2275(20)32360-9","article-title":"Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates","volume":"41","author":"Lee","year":"2000","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0070","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1161\/01.CIR.0000143163.76212.0B","article-title":"ACAT2 is localized to hepatocytes and is the major cholesterol-esterifying enzyme in human liver","volume":"110","author":"Parini","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154861_bb0075","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.4155\/fmc.15.161","article-title":"ACAT1\/SOAT1 as a therapeutic target for Alzheimer\u2019s disease","volume":"7","author":"Shibuya","year":"2015","journal-title":"Future Med Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0080","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature17412","article-title":"Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism","volume":"531","author":"Yang","year":"2016","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2021.154861_bb0085","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.21873\/anticanres.13482","article-title":"Acyl-coenzyme A:cholesterol acyltransferase inhibition in cancer treatment","volume":"39","author":"Zabielska","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0090","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1042\/BJ20051417","article-title":"Human acyl-CoA:cholesterol acyltransferase 2 gene expression in intestinal Caco-2 cells and in hepatocellular carcinoma","volume":"394","author":"Song","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.metabol.2021.154861_bb0095","first-page":"1328","article-title":"Avasimibe Pfizer","volume":"3","author":"Burnett","year":"2002","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.metabol.2021.154861_bb0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1527-3466.2003.tb00104.x","article-title":"Pharmacology of the ACAT inhibitor avasimibe (CI-1011)","volume":"21","author":"Llaverias","year":"2003","journal-title":"Cardiovasc Drug Rev"},{"key":"10.1016\/j.metabol.2021.154861_bb0105","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1161\/01.CIR.0000147777.12010.EF","article-title":"Effects of the acyl coenzyme A:cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions","volume":"110","author":"Tardif","year":"2004","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154861_bb0110","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/toxsci\/59.2.324","article-title":"Preclinical safety evaluation of avasimibe in beagle dogs: an ACAT inhibitor with minimal adrenal effects","volume":"59","author":"Robertson","year":"2001","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.metabol.2021.154861_bb0115","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm960674d","article-title":"Inhibitors of acyl-CoA: cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. CI-1011: an acyl sulfamate with unique cholesterol-lowering activity in animals fed noncholesterol-supplemented diets","volume":"39","author":"Lee","year":"1996","journal-title":"J Med Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0120","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0021-9150(97)00189-5","article-title":"CI-1011 lowers lipoprotein(a) and plasma cholesterol concentrations in chow-fed cynomolgus monkeys","volume":"136","author":"Ramharack","year":"1998","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154861_bb0125","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/S0022-2275(20)33494-5","article-title":"Inhibition of ACAT by avasimibe decreases both VLDL and LDL apolipoprotein B production in miniature pigs","volume":"40","author":"Burnett","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0021-9150(00)00615-8","article-title":"Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemia","volume":"157","author":"Insull","year":"2001","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154861_bb0135","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.atherosclerosis.2003.07.011","article-title":"Avasimibe, an ACAT inhibitor, enhances the lipid lowering effect of atorvastatin in subjects with homozygous familial hypercholesterolemia","volume":"171","author":"Raal","year":"2003","journal-title":"Atherosclerosis."},{"key":"10.1016\/j.metabol.2021.154861_bb0140","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1021\/nn504025a","article-title":"Avasimibe encapsulated in human serum albumin blocks cholesterol esterification for selective cancer treatment","volume":"9","author":"Lee","year":"2015","journal-title":"ACS Nano"},{"key":"10.1016\/j.metabol.2021.154861_bb0145","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2014.01.019","article-title":"Cholesteryl ester accumulation induced by PTEN loss and PI3K\/AKT activation underlies human prostate cancer aggressiveness","volume":"19","author":"Yue","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154861_bb0150","article-title":"Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation","volume":"13","author":"Li","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2021.154861_bb0155","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/s41586-019-0987-8","article-title":"Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma","volume":"567","author":"Jiang","year":"2019","journal-title":"Nature."},{"key":"10.1016\/j.metabol.2021.154861_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179558","article-title":"Cholesterol esterification inhibition and imatinib treatment synergistically inhibit growth of BCR-ABL mutation-independent resistant chronic myelogenous leukemia","volume":"12","author":"Bandyopadhyay","year":"2017","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2021.154861_bb0165","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/NEN.0b013e3181e77ed9","article-title":"The acyl-coenzyme A:cholesterol acyltransferase inhibitor CI-1011 reverses diffuse brain amyloid pathology in aged amyloid precursor protein transgenic mice","volume":"69","author":"Huttunen","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.metabol.2021.154861_bb0170","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1096\/fj.09-134999","article-title":"Inhibition of acyl-coenzyme A:cholesterol acyl transferase modulates amyloid precursor protein trafficking in the early secretory pathway","volume":"23","author":"Huttunen","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.metabol.2021.154861_bb0175","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1194\/jlr.M081745","article-title":"In vitro exploration of ACAT contributions to lipid droplet formation during adipogenesis","volume":"59","author":"Zhu","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0180","doi-asserted-by":"crossref","first-page":"19306","DOI":"10.1074\/jbc.RA119.011160","article-title":"Enhanced acyl-CoA:cholesterol acyltransferase activity increases cholesterol levels on the lipid droplet surface and impairs adipocyte function","volume":"294","author":"Xu","year":"2019","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0089365","article-title":"Dietary quercetin supplementation in mice increases skeletal muscle PGC1alpha expression, improves mitochondrial function and attenuates insulin resistance in a time-specific manner","volume":"9","author":"Henagan","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.metabol.2021.154861_bb0190","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1136\/gut.2010.215665","article-title":"Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models","volume":"59","author":"Murphy","year":"2010","journal-title":"Gut."},{"key":"10.1016\/j.metabol.2021.154861_bb0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jff.2015.05.008","article-title":"Dietary selenate attenuates adiposity and improves insulin sensitivity in high-fat diet-induced obese mice","volume":"17","author":"Kim","year":"2015","journal-title":"J Funct Foods"},{"key":"10.1016\/j.metabol.2021.154861_bb0200","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1053\/j.gastro.2008.12.051","article-title":"Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice","volume":"136","author":"Xue","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1016\/j.metabol.2021.154861_bb0205","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia."},{"key":"10.1016\/j.metabol.2021.154861_bb0210","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2021.154861_bb0215","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrendo.2017.161","article-title":"Animal models of obesity and diabetes mellitus","volume":"14","author":"Kleinert","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2021.154861_bb0220","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122289","article-title":"Fat fibrosis: friend or foe?","volume":"3","author":"Datta","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.metabol.2021.154861_bb0225","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1152\/ajpendo.00174.2017","article-title":"Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity","volume":"315","author":"Huang","year":"2018","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.metabol.2021.154861_bb0230","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bcp.2016.05.005","article-title":"Adipose extracellular matrix remodelling in obesity and insulin resistance","volume":"119","author":"Lin","year":"2016","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.metabol.2021.154861_bb0235","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.metabol.2021.154861_bb0240","first-page":"1548","article-title":"Effect of inhibiting ACAT-1 expression on the growth and metastasis of Lewis lung carcinoma","volume":"18","author":"Bi","year":"2019","journal-title":"Oncol Lett"},{"key":"10.1016\/j.metabol.2021.154861_bb0245","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1038\/onc.2016.168","article-title":"Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer","volume":"35","author":"Li","year":"2016","journal-title":"Oncogene."},{"key":"10.1016\/j.metabol.2021.154861_bb0250","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1161\/01.CIR.103.13.1778","article-title":"Acyl-CoA:cholesterol acyltransferase inhibitor avasimibe reduces atherosclerosis in addition to its cholesterol-lowering effect in ApoE*3-Leiden mice","volume":"103","author":"Delsing","year":"2001","journal-title":"Circulation."},{"key":"10.1016\/j.metabol.2021.154861_bb0255","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/hep.510300230","article-title":"Acyl-coenzyme A:cholesterol acyltransferase inhibitor, avasimibe, stimulates bile acid synthesis and cholesterol 7alpha-hydroxylase in cultured rat hepatocytes and in vivo in the rat","volume":"30","author":"Post","year":"1999","journal-title":"Hepatology."},{"key":"10.1016\/j.metabol.2021.154861_bb0260","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ebiom.2019.10.044","article-title":"Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator","volume":"49","author":"Pan","year":"2019","journal-title":"EBioMedicine."},{"key":"10.1016\/j.metabol.2021.154861_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbrc.2018.02.122","article-title":"Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet","volume":"499","author":"Xu","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2021.154861_bb0270","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1194\/jlr.R400004-JLR200","article-title":"Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal","volume":"45","author":"Dietschy","year":"2004","journal-title":"J Lipid Res"},{"key":"10.1016\/j.metabol.2021.154861_bb0275","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nn0403-345","article-title":"Alzheimer\u2019s disease: the cholesterol connection","volume":"6","author":"Puglielli","year":"2003","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.metabol.2021.154861_bb0280","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jacl.2009.11.003","article-title":"Altered cholesterol and fatty acid metabolism in Huntington disease","volume":"4","author":"Block","year":"2010","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.metabol.2021.154861_bb0285","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cmet.2010.11.006","article-title":"Diabetes and insulin in regulation of brain cholesterol metabolism","volume":"12","author":"Suzuki","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2021.154861_bb0290","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.neuropharm.2008.02.019","article-title":"Lipid rafts, cholesterol, and the brain","volume":"55","author":"Korade","year":"2008","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.metabol.2021.154861_bb0295","doi-asserted-by":"crossref","first-page":"21873","DOI":"10.1074\/jbc.M112.346890","article-title":"Constitutive cholesterol-dependent endocytosis of melanocortin-4 receptor (MC4R) is essential to maintain receptor responsiveness to alpha-melanocyte-stimulating hormone (alpha-MSH)","volume":"287","author":"McDaniel","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.metabol.2021.154861_bb0300","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.0020081","article-title":"Changes in gene expression foreshadow diet-induced obesity in genetically identical mice","volume":"2","author":"Koza","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/j.metabol.2021.154861_bb0305","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1016\/j.neurobiolaging.2013.03.012","article-title":"Effects of a high-fat, high-cholesterol diet on brain lipid profiles in apolipoprotein E epsilon3 and epsilon4 knock-in mice","volume":"34","author":"Lim","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.metabol.2021.154861_bb0310","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1073\/pnas.0913828107","article-title":"ACAT1 gene ablation increases 24(S)-hydroxycholesterol content in the brain and ameliorates amyloid pathology in mice with AD","volume":"107","author":"Bryleva","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.metabol.2021.154861_bb0315","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuron.2004.08.043","article-title":"The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer\u2019s disease","volume":"44","author":"Hutter-Paier","year":"2004","journal-title":"Neuron."},{"key":"10.1016\/j.metabol.2021.154861_bb0320","doi-asserted-by":"crossref","first-page":"16943","DOI":"10.1021\/acsomega.9b02307","article-title":"Brain targeting of acyl-CoA:cholesterol O-acyltransferase-1 inhibitor K-604 via the intranasal route using a hydroxycarboxylic acid solution","volume":"4","author":"Shibuya","year":"2019","journal-title":"ACS Omega"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952100161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604952100161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:28:33Z","timestamp":1758428913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604952100161X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":64,"alternative-id":["S002604952100161X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154861","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological inhibition of acyl-coenzyme A:cholesterol acyltransferase alleviates obesity and insulin resistance in diet-induced obese mice by regulating food intake","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2021.154861","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"154861"}}